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Background: The one-sample fecal immunochemical test (FIT) is gaining popularity for colorectal cancer (CRC)
screening of average-risk people. However, uptake and annual use remain suboptimal.
Methods: In 2013, we mailed questionnaires to three groups of nonHispanic White, Black, and Latino Kaiser
Permanente Northern California (KPNC) members ages 52–76 who received FIT kits in 2010–2012: Continuers did
the FIT all 3 years; Converts in 2012, but not 2010 or 2011; and Nonusers in none of the 3 years. The questionnaires
covered social influences, perceived CRC risk, reasons for using (Continuers, Converts) or avoiding using (Nonusers)
the FIT, and recommendations for improving the kit.
Results: Continuers (n = 607, response rate 67.5 %), Converts (n = 317, response rate 35.6 %), and Nonusers (n = 215,
response rate 21.1 %) did not differ in perceived risk or family history of CRC, but Nonusers were less likely than
Continuers and Converts to know someone who had polyps or CRC. Continuers, Converts, and Nonusers did not
differ in social network encouragement of CRC screening, but did differ in believing that it was very important that
they be screened (88.3 %, 68.4 %, 47.7 %) and that their medical team thought it very important that they be
screened (88.6 %, 79.9 %, 53.9 %). Approximately half of Continuers and Converts completed the FIT to please their
doctor. Converts were less likely than Continuers to use the FIT to “make sure they were OK” (53.7 % vs. 72.6 %) or
“protect their health” (46.1 % vs. 76.4 %). Nearly half of Converts completed the FIT out of guilt. Approximately half
of FIT kit users suggested adding a disposable glove, extra paper, and wider-mouth tube to the kit. Nonusers’
reasons for not using the FIT included discomfort, disgust, or embarrassment (59.6 %); thinking it unnecessary
(32.9 %); fatalism/fear (15.5 %); and thinking it too difficult to use (14.5 %), but <10 % did not want CRC screening at all.
Conclusions: Nonusers and irregular users of the FIT are less intrinsically motivated to get CRC screening than
long-term users and more averse to preparing their stool sample. Changes to the FIT kit to address discomfort
and difficulty factors might improve uptake and continued use.
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Colorectal cancer (CRC) is the third leading cause of
cancer deaths in the United States [1]. The United States
Preventive Services Task Force has recommended that
adults ages 50–75 be screened for CRC by one of three
evidence-based methods: an annual high-sensitivity fecal
occult blood test (FOBT) , flexible sigmoidoscopy every
five years, or colonoscopy every ten years [2]. Yet, on aver-
age, only 65 % of Americans are meeting recommended
guidelines for CRC screening [3]. Patient-reported barriers
to CRC screening include failure of physicians to rec-
ommend screening, scheduling difficulties, cost, lack of
insurance coverage, gaps in knowledge, fear, embarrass-
ment, pain, aversion, lack of symptoms, and perceived
low risk [4–9].
Many of these previous studies have focused on sig-
moidoscopy and colonoscopy for CRC screening. Some
patients who have undergone or know someone who has
undergone CRC screening describe these methods as in-
vasive, uncomfortable, and inconvenient because they
must be done in a medical setting and require a colonos-
copy bowel preparation prior to the procedure. FOBTs
and the newer fecal immunochemical test (FIT) are rec-
ommended to be done annually rather than every ten
years, but in contrast to colonoscopy, are done at home
and involve no special preparation. Studies have shown
that offering the newer FIT, which involves no dietary
restrictions prior to the test and requires preparation of
only one stool sample (versus three for the FOBT), re-
sults in higher uptake than the FOBT [10–15]. However,
despite the convenience factor, uptake of the FIT is still
suboptimal (50–70 %).
Reasons for not completing the stool-based CRC
screening tests (primarily the FOBT) include feeling
healthy, believing oneself to be at low risk, having no
CRC symptoms, fearing results of a positive screening
test requiring a follow-up colonoscopy, and not wanting
to know if CRC is present [5, 16–21]. Barriers specific to
the test itself include difficulty understanding the in-
structions for how to take and prepare the stool sample;
concerns about handling, storing, and mailing the stool
sample; concern about test accuracy; and a preference
for a doctor to do such tests [5, 8, 22–24].
In 2005, in an effort to boost CRC screening rates, the
Kaiser Permanente Medical Care Program in Northern
California (KPNC) implemented a centralized outreach
effort to promote CRC screening for members at average
risk using mailed FIT kits [25]. Strategic enhancements
to encourage use of the kit (e.g., test was free for all
members, letter from primary care provider, multiple re-
minders, and multiple kit mailings) resulted in 68 % of
the 500,500 member outreach cohort ages 50–75 (65 %
of 50–64 year olds and 78 % of 65–75 year olds) com-
pleting the FIT in 2012.To identify steps that could be taken to increase up-
take and annual use of the FIT and improve overall
CRC screening outreach efforts, we conducted a survey
of three groups of health plan members who were in
FIT kit outreach cohorts for three consecutive years
(2010–2012). “Continuers” were people who completed
the FIT all three years; “Converts” completed the FIT in
2012, but not in 2010 or 2011; and “Nonusers” did not
complete the FIT in any of these years. The aims of the
survey were to learn (1) about the roles of physicians
and other social influences, beliefs related to CRC
screening, and other factors that motivated use or non-
use of the FIT kit, and how these differed across the
three groups; (2) the extent to which characteristics of
the FIT kit, including modifiable components, might be
affecting uptake by Nonusers and leading to irregular use
among some kit users; and (3) whether there are racial/
ethnic, age, or sex differences in motivations and barriers
for using the FIT kit or for being screened for CRC that
could inform CRC screening outreach programs.
Methods
Study setting
In 2012, during January to July, 500,550 health plan mem-
bers ages 50–75 who were due for CRC screening were
sent a computer-generated letter from their primary care
doctor telling them that the FIT kit was coming, why it
was important to get screened for CRC, and that the
test was free to all members. The FIT kit (Polymedco
OC FIT-CHEK®) arrived at their home approximately
one week later with a multilingual flyer about the im-
portance of being screened for CRC and a pre-paid
cardboard mailer to send the stool sample to the pro-
cessing lab. Members who did not send in their com-
pleted FIT sample received an automated phone
reminder approximately four weeks after the mailing
and a follow-up letter two weeks after that. During August
to October, those who had not yet completed the FIT were
sent a second FIT kit. In addition, medical facilities
were encouraged to implement CRC screening “inreach”
activities, offering members whose electronic health
record showed they were past due for CRC screening a
FIT kit at primary care visits or flu shot clinics. Among
English speakers (the only language group included in
this study), approximately 71 % of nonHispanic Whites
(WhiteNH), 66 % of Blacks, and 64 % of Latinos in the
2012 outreach cohort completed the FIT.
Study sample
The study population included three groups of health
plan members ages 52 to 76 who received mailed FIT
kits in three consecutive years (2010, 2011, and 2012).
The study groups were retrospectively created by identi-
fying 2012 FIT completion status and then looking back
Gordon and Green BMC Public Health  (2015) 15:546 Page 3 of 12at 2010 and 2011 completion status. “Continuers” com-
pleted the FIT in all three years; “Converts” completed the
FIT in 2012, but not in 2010 or 2011; and “Nonusers” did
not complete the FIT in any of the three years. The three
study groups were linked with member race/ethnicity and
language preference data derived from a combination of
clinical, administrative, and research data sources; about
99 % had language preference data, and among those
whose language preference was English, 98 % of Con-
tinuers, 96 % of Converts, and 91 % of Nonusers were
matched to a race and ethnicity. From the identified
WhiteNH, Black, and Latino English speakers who were
still current health plan members, we selected stratified
random samples of 900 Continuers, 891 Converts, and
1020 Nonusers. All three study groups included approxi-
mately equal numbers of WhiteNH, Black, and Latino
men and women who were ages 52–64 or 65–76 at the
time of the survey.
Data collection
Questionnaire items were derived from previously pub-
lished results of focus group and survey research about
factors associated with use or avoidance of the FOBT
[5, 26–31] and results of qualitative interviews conducted
with KPNC members in 2012. Most questions employed a
checklist format that also allowed respondents to write in
their own free-text responses.
Continuers and Converts received the same brief (3-page)
questionnaire, and Nonusers received a different ques-
tionnaire that had many items overlapping with the
Continuer/Convert questionnaire (see Additional file 1).
The print survey materials were mailed in August 2013,
with a second survey packet sent to nonrespondents
approximately five weeks later. The survey could also
be completed online. Participants were offered a $10
gift card for completing the survey. This study was ap-
proved by the Kaiser Foundation Research Institute’s
Institutional Review Board.
Data analysis
Respondent data were weighted back to the race/ethnicity
(WhiteNH, Black, and Latino) × age group (52–64,
65–76) × sex strata of the study population Continuer,
Convert, and Nonuser groups from which they were
sampled. All analyses were performed using SAS ver-
sion 9.3 [32]. Weighted percentages were produced by
using SAS Proc Surveymeans. SAS Proc Surveylogistic
was used to test for significant differences between
study groups after adjusting for the demographic factors
using multivariable models that included race/ethnicity
(Black, Latino vs. WhiteNH), age group (65–76 vs.
52–64), sex (female vs. male), and study group (Convert
vs. Continuer or Convert, Nonuser vs. Continuer). A Wald
chi-square value with P < .05 was considered statisticallysignificant. All comparisons cited as statistically significant
in the text met the P < .05 threshold.
Results
Survey response rate and exclusions
The response rate after two mailings was 67.5 % (607/899)
for the Continuer group, 35.6 % (317/890) for the Convert
group, and 11.7 % (119/1017) for the Nonuser group,
although the Nonuser sample was increased to 21.1 %
(215/1017) with the addition of data from an abbreviated
phone interview with a sample of 100 nonrespondents.
Across all three groups, there was no difference in re-
sponse by age (52–64 vs. 65–76), but WhiteNHs were
slightly more likely to respond than Blacks and Latinos
(see Additional file 2). After data collection, 5 Continuers,
3 Converts, and 1 Nonuser were excluded when we found
that they were not in of any the three racial/ethnic groups
being studied; 1 Continuer, 1 Converts, and 3 Nonusers
were removed from the original survey sample during data
collection due to leaving the health plan (n = 1) or unavail-
ability of a current mailing address (n = 4).
Demographic and health characteristics of the study
groups
The final Continuer, Convert, and Nonuser respondent
groups were very similar with regard to age, sex, and ra-
cial/ethnic composition prior to applying the weighting
factor (not shown). Table 1 shows a comparison of these
groups using weighted data. Compared to the Continuer
group, the Convert and Nonuser groups had significantly
higher percentages of 52–64 year olds and non-WhiteNH.
Continuers and Converts were similar with regard to edu-
cation, family history of CRC, personal history of any type
of cancer, daily low-dose aspirin use, and most of the diet-
ary practices. However, Converts were significantly less
likely than Continuers to have a history of irritable bowel
syndrome (P < .05) and to say they ate a lot of high-fiber
foods or took a fiber supplement (P < .001). Compared
with Continuers and Converts, Nonusers were signifi-
cantly less likely to have attended any college (P < .001)
and significantly less likely to know someone with a his-
tory of colon polyps or CRC (P < .001).
Differences in physician and social network influences on
use of the FIT kit
Converts and Nonusers were significantly more likely
than Continuers to indicate that their doctor had dis-
cussed CRC screening in general or specifically the FIT
with them (52.6 % and 62.4 % vs. 35.1 %, respectively).
This was not unexpected, because physicians were asked
to discuss CRC screening with patients who were past
due for screening as part of the outreach strategy. There
were no significant differences between Continuers and
Converts in the types of people who encouraged them to
Table 1 Characteristics of respondents (after weighting)
Continuers + Converts Continuers Converts Nonusers
(N = 916) (N = 602) (N = 314) (N = 214)1
Wtd. % (n) Wtd. % (n) Wtd. % (n) Wtd. % (n)
Group (% Continuers) 90.6 (602) 100 (602) – –
Sex and age
Female 52–64 38.0 (207) 35.0 (123) 43.7 (84) 41.4 (48)
Male 52–64 31.8 (202) 29.3 (140) 36.6 (62) 37.7 (46)
Female 65–76 17.0 (249) 20.0 (163) 11.2* (86) 11.9* (60)
Male 65–76 13.2 (258) 15.7 (176) 8.5* (82) 9.0* (60)
Race/ethnicity
nonHispanic White 82.4 (343) 83.0 (220) 76.7*(123) 76.2* (74)
Black 8.1 (276) 7.8 (182) 10.3 ( 94) 10.3 (67)
Hispanic/Latino 9.5 (297) 9.1 (200) 13.0 ( 97) 13.5 (73)
Education
< 12 years 2.3 ( 54) 2.3 ( 34) 2.5 ( 20) 3.9 ( 11)
High school graduate/GED 15.7 (204) 15.4 (146) 18.2 ( 58) 25.5 ( 64)
Some college 36.3 (348) 36.4 (232) 35.3 (116) 30.9 ( 79)
College graduate 45.7 (329) 45.9 (214) 44.0 (115) 39.7* (56)
In a committed relationship 78.7 (647) 79.5 (439) 70.7 (208) 73.2 (143)
Other
Personal history of cancer 11.1 ( 83) 11.3 ( 59) 8.6 (24) 7.8 (20)
Family history of CRC 12.1 ( 99) 12.3 ( 63) 10.2 (36) 7.7 (15)
Knows someone who had CRC or pre-cancerous polyps 35.9 (272) 36.3 (186) 32.5 (86) 29.4* (40)
Recalls getting more than 1 FIT kit in the mail in 2012 30.8 (225) 12.4 ( 67) 54.7 (158) 57.3 ( a )
Wtd weighted, GED general education development (high school equivalency exam), CRC colorectal cancer, FIT fecal immunochemical test
*Significantly different (P < .05) from Continuer group after adjusting for age group and race/ethnicity
aNot asked in the abbreviated interview
1Data for Nonusers comes from 118 people who completed the questionnaire and 96 people who completed a phone interview that asked a subset of the
questions. Demographic characteristics for the two groups did not differ significantly
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groups, men were significantly more likely than women
to identify at least one person in their social network
who had encouraged them to get CRC screening.
Among men, this was most frequently their spouse/part-
ner. Sources of encouragement among women tended to
be other relatives or friends. Very few people indicated
getting encouragement from employers or religious
leaders (ministers, priests, or rabbis). Nonusers did not
significantly differ from Converts with regard to having
discussed CRC screening with their doctor and other
sources of encouragement, and there were no significant
racial/ethnic differences in social network encourage-
ment for CRC screening.
Differences in beliefs about personal CRC risk and
importance of getting screened
Perceived level of risk for developing CRC
There was no significant difference in perceived risk of
developing CRC across the three groups. Approximately60 % of adults believed they were at very low or low
risk, about one-fourth thought they were at medium or
high risk, and the rest were not sure of their risk (see
Additional file 3).
Belief that the respondent’s medical care team thinks it is
very important for the respondent to get screened
Continuers (88.6 %) were significantly more likely than
Converts (79.9 %), who were significantly more likely
than Nonusers (53.9 %, based on questionnaire re-
sponders only) to think that it is very important to their
medical care team that they get screened for CRC (see
Additional file 4), and these significant group differences
remained after adjusting for age group, race/ethnicity,
and sex. Although belief about importance to the medical
care team did not significantly differ by sex or age group,
the Continuer-Convert difference was statistically signifi-
cant for Whites (88.2 % vs. 75.4 %) and Latinos (92.3 %
vs. 79.4 %), but not Blacks (88.7 % vs. 83.8 %). Racial/
ethnic differences in the Nonuser group could not be
Table 2 Responses to the question “Aside from your doctor, who has encouraged you to get screened for CRC?”
Continuers Converts Nonusers
Men Women Men Women Men Women
(n = 314) (n = 286) (n = 142) (n = 309) (n = 106) (n = 108)
Wtd. % Wtd. % Wtd. % Wtd. % Wtd. % Wtd. %
Any family member 58.2 33.8* 65.7 41.6 67.6 35.9*
Spouse/partner
All 50.9 23.1* 57.3 23.5* 64.8 26.9*
Those with a spouse/partner 59.6 31.5* 70.3 36.5* 76.5 37.9*
Children/grandchildren 4.3 5.0 2.7** 11.1* 2.1 8.3*
Other relatives 10.7 12.9 10.6 11.8 6.6 15.7*
Friends or co-workers 8.6 15.1 17.1 19.4 3.1 12.9*
Employer 0.1 0.1 1.8 2.8 0 7.9
Minister, priest, or rabbi 0.1 0.1 0.5 0.3 0 3.6
None of these relationships 39.8 57.2* 29.1 45.6 28.8 50.0*
Wtd weighted, CRC colorectal cancer
*Significant (P < .05) difference between the sexes in the same group, after adjusting for age group and race/ethnicity
**Significant (P < .05) difference between Converts and Continuers within sex group after adjusting for age group and race/ethnicity
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after adjusting for race/ethnicity, we found no significant
age group or sex differences in beliefs about the import-
ance of screening to subjects’ medical teams.
Personal belief that it is very important to get screened
Continuers (86.8 %) were significantly more likely than
Converts (68.4 %), and Converts were significantly more
likely than Nonusers (47.4 %) to think it is very important
that they get screened for CRC (see Additional file 5). The
difference in percentages of Continuers and Converts hold-
ing this belief was statistically significant for WhiteNHs
(85.9 % vs. 65.9 %), Blacks (95.2 % vs. 84.6 %), and Latinos
(88.3 % vs. 69.6 %). For both Continuers and Converts,
Blacks were significantly more likely than WhiteNHs to
think that getting CRC screening was very important.
Logistic regression models run separately for Con-
tinuers, Converts, and Nonusers found a significantly
positive association between believing that it is very im-
portant to get screened and believing that one’s medical
care team thinks it is very important to be screened
(Continuers: χ2 = 34.5, P < .001; Converts: χ2 = 23.8,
P < .001; Nonusers: χ2 = 24.6, P < .001) after adjusting for
sex, age group, and race/ethnicity. Similar models found
a significant negative association between belief that it is
very important to get screened and belief that one does
not have a medium or high risk of developing CRC
(Continuers: χ2 = 4.7, P < .05; Converts: χ2 = 7.2, P < .01;
Nonusers χ2 = 10.6, P < .01). When belief about personal
CRC risk and belief about importance to one’s clinicians
were both entered into the logistic model, the latter
remained strongly significant for all three groups. Per-
ceived CRC risk remained statistically significant (χ2 = 5.5,P < .05) for Continuers and Nonusers (χ2 = 5.5, P < .02),
but not for Converts (χ2 = 2.2, P > .10).
Awareness of need to complete the FIT annually for
effective screening
Converts and Nonusers were significantly less likely than
Continuers to know that the FIT needs to be done every
year to be effective for CRC screening (72.8 % and 42.9 %
vs. 90.4 %, respectively).
Awareness of time frame for use of the FIT kit and sending
in the sample
The FIT kit has a shelf life of about ten months, but we
found that across all three study groups, approximately
75 % of people thought that the FIT kit needed to be
used within four weeks of receipt. Continuers were sig-
nificantly more likely than Converts to think that the
test needs to be completed within two weeks (56.6 % vs.
30.9 %, χ2 = 18.8, P < .0001). Also, unless the ambient air
is very warm, the stool sample can be processed up to
fourteen days after being put in the tube, meaning that it
could be mailed or dropped off 7–8 days after the sam-
ple is prepared. We found that 85 % of Continuers and
Converts thought that their sample needed to be in the
mail within three days, and 95 % thought within five
days; among Nonusers, 70 % thought it needed to be
mailed within five days and nearly 25 % thought it was
OK to mail it ten days later.
Reasons indicated by Continuers and Converts for
completing the FIT
Over half of men in the Continuer and Convert groups and
half of women in the Convert group said they completed
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women in the Continuer group were significantly less likely
than men in that group to say this (χ2 = 6.19, P < .02, after
adjusting for age and race/ethnicity) (Table 3). In both
groups, Black men were significantly more likely than
WhiteNH men (χ2 = 4.5, P < .05) to say they did the FIT
because their doctor wanted them to, but no significant
racial/ethnic differences were observed for women.
In both groups, men were significantly more likely than
women to indicate that they did the FIT because their
spouse/partner really wanted them to (All: χ2 = 30.3,
P < .001; those in a committed relationship: χ2 = 24.5,
P < .001; models adjust for age group and race/ethni-
city). Among those in the Convert group who were in a
committed relationship, Blacks were significantly more
likely than WhiteNHs to indicate spouse/partner as
an important influence (Women: χ2 = 7.2, P < .01; men
χ2 = 3.9, P < .05). In both groups, women were signifi-
cantly more likely than men (χ2 = 11.0, P < .001) to indi-
cate that knowing a family member or friend who had
CRC or colon polyps motivated them to do the FIT.
In both groups, personal reasons were more frequently
endorsed than social influences as motivating FIT kit use.
However, after adjusting for age, sex, and race/ethnicity,
Continuers were significantly more likely than Converts
to indicate that they did the FIT to protect their healthTable 3 Reasons indicated by Continuers and Converts for complet




Those in a committed relationship
My children/grandchildren
I know someone with a history of CRC or colon polyps
Peace of mind/prevention
I wanted to make sure I was OK
FIT test can help me protect my health
When colorectal polyps are found and removed, CRC can be prevented
FIT is more convenient than other CRC screening methods
Felt guilty after receiving so many kits
All
Those who recalled getting >1 kita
Wtd weighted, FIT fecal immunochemical test, CRC colorectal cancer
*Significant (P < .05) difference between sexes within Continuer or Convert group af
**Significant (P < .05) difference between Convert and Continuer group within sex g
a43 (13.6 %) men and 59 (20.7 %) women in the Continuer group reported getting
Convert group reported getting multiple kits(76.4 % vs. 46.1 %, χ2 = 33.2, P < .0001), to make sure
they were OK (72.6 % vs. 53.7 %, χ2 = 14.0, P < .001),
and because CRC can be prevented if polyps are found
and removed (41.3 % vs. 22.7 %, χ2 = 11.9, P < .001).
Among both Continuers and Converts, Blacks were signifi-
cantly more likely than WhiteNHs to say they had done
the FIT to make sure they were OK (χ2 = 7.8, P < .01).
Continuers were significantly more likely than Con-
verts to indicate that they used the FIT kit because it
was more convenient than other CRC screening
methods (66.2 % vs. 41.0 %, χ2 = 20.3, P < .001). However,
among the Continuers, WhiteNHs were significantly
more likely than Blacks and Latinos to indicate conveni-
ence of the FIT as a reason for doing it.
Converts were significantly more likely than Continuers
to be motivated to do the FIT out of guilt from receiving
so many FIT kits (47.2 % vs. 4.6 %, χ2 = 66.4, P < .001).
Furthermore, 9 % of women in the Convert group indi-
cated guilt as the only reason they did the test.
After indicating all their reasons, participants were
asked to indicate their top two reasons. The results are
shown in Table 4. “Wanting to make sure I was OK” was
a top reason for both Continuer and Convert groups, as
well as for all races/ethnicities and both sexes. Doing the
FIT to help protect health ranked higher among Continuers
than Converts. Very low percentages of both groups (7 %ing the FIT in 2012
Continuers Converts Continuers Converts
All All Men Women Men Women
(N = 600) (N = 308) (N = 315) (N = 285) (N = 138) (N = 170)
Wtd. % Wtd. % Wtd. % Wtd. % Wtd. % Wtd. %
44.2 54.0 52.4 37.4* 58.5 50.5
19.4 23.2 33.4 7.8* 41.8 8.5 *
24.6 34.1 38.9 10.8* 53.2 13.9*
3.7 6.9 5.2 2.4 2.9 10.1*,**
27.3 20.1 17.8 35.2* 14.7 24.5
72.6 53.7** 68.9 75.7 51.2 ** 55.7**
76.4 46.1** 70.5 81.3* 38.5 ** 52.1**
41.3 22.7** 36.0 45.8 24.9 21.1**
66.2 41.0** 59.9 71.4* 35.2** 45.5**
4.6 47.2** 1.8 7.0 37.9** 54.5**
12.3 65.3** 0.7 12.7* 68.9** 63.4**
ter adjusting for age group and race/ethnicity
roup after adjusting for age group and race/ethnicity
multiple FIT kits whereas 69 (50.0 %) men and 114 (67.0 %) women in the
Table 4 Reasons most frequently cited as one of the top two motivations for doing the FIT in 2012
Continuers Converts Continuers Converts
All All Men Women Men Women
(N = 600) (N = 308) (N = 315) (N = 285) (N = 138) (N = 170)
Wtd. % Wtd. % Wtd. % Wtd. % Wtd. % Wtd. %
My doctor really wanted me to do it 18.9 28.3* 25.1 13.7** 25.9 30.2*
My spouse/partner really wanted me to do it (those in a committed relationship) 7.1 15.4* 12.5 2.0 26.8* 3.3
I wanted to make sure I was OK 35.1 26.6 36.9 33.6 23.6 29.0
FIT test can help me protect my health 33.0 15.5* 30.2 35.3 7.8* 21.6*,**
FIT is more convenient than other CRC screening methods 24.5 11.8* 19.8 28.4 8.5 14.5*
Felt guilty after receiving so many kits
All 1.1 27.0* 0.6 1.6 19.2* 33.1*
Those who recalled getting > 1 kita 2.0 38.7* 0.7 2.6 34.4* 41.1*
Wtd weighted, FIT fecal immunochemical test, CRC colorectal cancer
*Significant (P < .05) difference between Convert and Continuer group within sex group after adjusting for age group and race/ethnicity
**Significant (P < .05) gender difference within Continuer or Convert group after adjusting for age group and race/ethnicity
a43 (13.6 %) men and 59 (20.7 %) women in the Continuer group and 69 (50.0 %) men and 114 (67.0 %) women in the Convert group reported getting multiple kits
Gordon and Green BMC Public Health  (2015) 15:546 Page 7 of 12of Continuers and 6 % of Converts) ranked doing the test
for early detection and removal of polyps as a top reason.
Wanting to please their doctor was a top reason for men
and women in the Convert group and men in the Con-
tinuer group. Doing the FIT to please their spouse was a
top reason for a higher percentage of men in the Convert
than Continuer group, and doing it to please children was
endorsed as a top reason by no men and <2 % of women.
Guilt about having received multiple kits was a top reason
for approximately one-fourth of Converts overall and over
one-third of those who recalled receiving multiple kits.
Reasons indicated by Nonusers for not completing the FIT
Nonusers were given a list of reasons for not having
done the FIT and allowed to add others. Free-text rea-
sons that overlapped with checklist categories were
recoded prior to analysis. At least one reason was given
by 95 % (n = 204) of respondents, and these reasons
were grouped into three main categories (Table 5). Ap-
proximately 60 % of Nonusers endorsed feelings of dis-
comfort or disgust when they thought about the process
of getting, preparing, and/or mailing the stool sample, or
embarrassment about having anyone see that they were
going to do the test. For over half (54 %), these negative
feelings about the physical aspects of the FIT were the
main reason for not doing it. About 33 % did not think
it was necessary for them to get screened for CRC be-
cause they were feeling fine or they thought their CRC
risk was very low. Approximately 12 % were extremely
fearful about the test discovering cancer (“If I have colon
cancer, I don’t want to know”), but only 6 % were fatalis-
tic (“If I’m meant to get colon cancer, I will get it no
matter what”; “Even if colon cancer is detected early,
nothing can be done about it”). Concern about ability to
get the stool sample into the tube or use the catch paperwere indicated by about 15 %, and 8 % said they did not
want to worry while waiting for the results. Only 4 %
thought that the FIT was not going to be effective for
finding cancer early.
Other reasons for not doing the FIT that were not in
the original list included procrastination (7 %); a physical
disability, e.g., limited use of an arm, tremor, arthritis, or
poor eyesight that made it difficult to get the stool sam-
ple into the tube (1 %); hemorrhoids or severe constipa-
tion (3 %); fear of needing to have a colonoscopy if the
FIT result was positive (3 %); not wanting to pay for the
test, which was free (8 %); and having been screened
outside of the health plan (1 %). The most frequent of
these “other” responses are shown in Table 5. Blacks and
Latinos and people ages 65–76 were significantly more
likely than WhiteNHs and people ages 52–64, respect-
ively, to indicate procrastination. Latinos were signifi-
cantly more likely than WhiteNHs and Blacks (23.4 %
vs. 9.1 %, χ2 = 3.9, P < .05) to indicate that they did not
need to be screened because they felt fine.
Approximately 30 % of Nonusers had no interest in
using the FIT kit. However, less than 10 % said they
had absolutely no interest in being screened for CRC,
and 41 % indicated that they had been screened for
CRC in the past (21 % with a FOBT). Approximately 15 %
said that they would consider doing the FIT or other type
of CRC screening procedure if their doctor told them why
it is important for them to get screened.
Characteristics of the FIT kit that may be affecting FIT
uptake and possible changes to the kit to boost uptake
and continued use
Nonusers were not the only people who felt uncomfort-
able about the procedures involved with using the FIT
kit. Overall, 28 % of Continuers and Converts who did
Table 5 Nonusers’ reasons for not using the FIT
N = 204
Wtd. %
Feelings of discomfort, disgust, or embarrassment 59.6
The idea of doing this test involving my bowel
movement makes me uncomfortable
44.3
I feel disgusted by the idea of reaching into the toilet
to get the stool sample
29.5
It’s too messy to do this test 20.0
I don’t like the idea of sending my bowel movement
sample through the mail
15.5
I am concerned about coming into contact with germs
and bacteria
13.2
I am embarrassed to put the FIT kit by the toilet, but
then I keep forgetting to use it
10.5
CRC screening not necessary 32.9
I think my chances of developing CRC are very low 27.2
I feel fine, so why look for trouble 12.8
Fatalism or fear 15.5
If I have colon cancer, I don’t want to know 12.4
I think if I am meant to get colon cancer, I will get it no
matter what I do
5.3
I think that even if colon cancer is detected early, nothing
can be done about it
2.9
Other
I think it will be too hard for me to get the bowel
movement sample and put it in the tube; I tried to scoop
up a bit of the bowel movement and put it into the tube,
but it was too hard to do
14.5
I don’t want to have to worry until I get the results of
the test
8.1
I don’t want to have to pay for this test 8.0
Procrastination (e.g., “I just kept putting it off”) 7.2
I used the FIT kit to get the sample, but then forgot to
put the envelope in the mail right away
6.5
I don’t think that the FIT test is effective for finding
cancer early
4.2
Worried that I will need a follow-up colonoscopy and I don’t
want to get one
3.1
Have problems with my bowel movements (constipation,
hemorrhoids)
3.0
Wtd weighted, FIT fecal immuochemical test, CRC colorectal cancer
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agreed that they were concerned about coming into con-
tact with germs/bacteria in the toilet water or bowel
movement. As shown in Fig. 1, Converts were significantly
more likely than Continuers, and Blacks and Latinos sig-
nificantly more likely than WhiteNHs, to be concerned
about coming into contact with germs or bacteria in the
toilet water while getting their stool sample. Paralleling
this concern, Converts were significantly more likely than
Continuers (47.2 % vs. 26.5 %, χ2 = 13.6, P < .001, after
adjusting for age, race/ethnicity, and sex), and Blacks weresignificantly more likely than WhiteNHs (40.5 % vs. 26.5 %,
χ2 = 7.6, P < .01) to use their own disposable glove when
doing the FIT. Further, when asked about changes they
would recommend to the FIT kit to make it easier to use
(Table 6), about 55 % of Continuers and Converts recom-
mended including a disposable glove, with 27 % indicating
that as their highest priority change. One-third of Con-
tinuers and Converts also recommended including an anti-
bacterial wipe (highest priority change for 7 %).
Approximately 30 % of respondents who did the FIT in
2012 indicated that they sometimes had trouble catching
their bowel movement sample on the paper provided, and
25 % said they sometimes had trouble getting the sample
into the tube: 8.4 % disagreed and 21.9 % somewhat
agreed with the statement “I have no trouble catching my
bowel movement sample on the paper laid in the toilet”
(the other category, “strongly agreed”, was interpreted as
having no problem), and 5.6 % disagreed and 19.1 % some-
what agreed with the statement “I have no trouble getting
the sample into the tube.” Paralleling these problems, over
half of Continuers and Converts recommended including
an extra sheet of paper (highest priority change for 32 %),
46 % requested a tube with a wider opening (highest prior-
ity change for 28 %), and 20 % wanted a longer poke stick
(highest priority change for 5 %). From free-text com-
ments, we surmised that the request for the extra sheet of
paper is likely associated with misconception that the
bowel movement sample becomes contaminated if it
comes into contact with urine in the toilet bowl.
Blacks and Latinos were significantly more likely than
WhiteNHs to want the disposable glove, an antibacter-
ial wipe, and a longer poke stick, and Blacks were also
more likely to request a wider-mouth tube. Women
were significantly more likely than men (60.1 % vs. 47.4 %,
χ2 = 4.4, P < .05) to request the inclusion of a glove. Con-
tinuers and Converts only differed significantly with re-
gard to a request for simpler instructions (5.9 % vs.
14.7 %, respectively, χ2 = 10.2, P < .001).
Nonusers were also asked whether any of these changes
would make them more likely to use the FIT kit in the
future. Of the 117 who answered, the glove was indi-
cated by 67 %, the extra sheet of paper and antibacterial
wipe by 45 %, the longer poke stick and tube with wider
mouth by 29 %, and simpler instructions by 10 %. There
were no significant racial/ethnic or sex differences.
Discussion
Our cross-sectional survey of three types of responders to
a centralized FIT kit outreach program within an inte-
grated health care program identified several differences
in beliefs and concerns associated with FIT kit use be-
tween continuous users, people who had avoided doing
the FIT for at least two years but did it in the outreach
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Fig. 1 Percentages who agreed with statement: I am concerned about coming into contact with germs or bacteria in the toilet water or bowel
movement”. aSignificantly greater than Continuers (P < .05, Wald chi-square test); bSignificantly greater than WhiteNH (P < .05, Wald chi-square test) after
adjusting for age, sex, and study group or race/ethnicity
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sistently for several years, the most frequently cited main
motivations were intrinsic, i.e., “checking to make sure
I’m OK” or “to protect my health.” As a group, they were
more likely than non-routine FIT users to believe that it
is very important for them to get screened for CRC.
Among men, the doctor and spouse/partner (if in a rela-
tionship) was a major motivator for doing the FIT, but
this was less true for women. Convenience of the FIT for
CRC screening was a more important feature for
WhiteNHs than for Blacks and Latinos.
Among people who did the FIT in 2012 after ignoring
outreach efforts for at least two years, social influence
(from their doctor or partner) and guilt were most fre-
quently cited as reasons for doing it this time, with sig-
nificantly lower percentages citing intrinsic motivations.Table 6 Changes to FIT kit recommended by people who used
the FIT kit in 2012
Recommended Changes
to FIT Kit
All WhiteNH Black Latino
(N = 799) (N = 272) (N = 252) (N = 275)
Wtd. % Wtd. % Wtd. % Wtd. %
Include an extra sheet
of paper
56.7 56.3 61.3 55.8
Include a disposable
glove
54.7 51.8 68.7* 63.9*
Make tube mouth wider 46.9 45.2 58.9* 49.2
Include an antibacterial
wipe
33.9 30.5 52.2 * 44.0*
Make poke stick longer 19.7 17.6 29.3* 27.2*
Simplify the instructions 6.8** 6.3 9.1 8.8
Post a video demonstration
of how to use the FIT kit
6.8 5.9 10.2 10.7
Wtd weighted, WhiteNH nonHispanic White, FIT fecal immunochemical test
*Significant (P < .05) difference compared to WhiteNH after adjusting for age
group, sex, and study group
**Significant (P < .05) difference between Convert and Continuer group after
adjusting for age group, sex, and race/ethnicityHowever, Converts were less likely than Continuers to
believe that it was very important to their medical care
team and to themselves personally that they be screened.
They were also more concerned than Continuers about
handling their stool sample (e.g., they used a glove), less
likely to indicate that the FIT was a convenient way to
get CRC screening, and less likely to know that the FIT
needs to be done annually to be effective for CRC
screening. Those Converts who do not internalize the
benefits of using the FIT for CRC screening or do not
accept that it needs to be done annually are likely at ele-
vated risk for not continuing to do the FIT annually.
Among people who have been avoiding doing the FIT,
feeling uncomfortable or visceral disgust with the
process of getting their stool sample out of the toilet and
getting it into the tube is a major barrier to uptake. We
suspect that many of those who only indicated procras-
tination as their reason for not doing the FIT were also
avoiding it due to discomfort or embarrassment. For
some, these feelings are based on past experience doing
FOBTs, while for others, just the idea of doing the FIT is
upsetting (e.g., one woman interviewed said she was so
disgusted by the thought of doing the test that she got
nauseous just talking about it). This disgust factor has
also been found in previous studies [5, 8, 28, 30]. Based
on what Nonusers told us, we think that many FIT
avoiders are not convinced that the personal benefits of
doing the FIT outweigh the costs (feelings of discomfort,
disgust, or embarrassment related to preparing and
sending their stool sample), especially if they think they
are at low risk for CRC. Most people who have been
avoiding doing the FIT did not say they are not inter-
ested in being screened for CRC, just that they did not
like using a stool test.
We believe that the majority of people who have
avoided doing the FIT for several years, despite outreach
efforts, have developed resistance to the idea of doing
Gordon and Green BMC Public Health  (2015) 15:546 Page 10 of 12the FIT that is not going to be overcome by different
outreach messaging—they do not even want to think
about or talk about doing a stool test. This is in keeping
with Duncan et al. that the behavior of refusing multiple
CRC screening offers is different from the behavior of
refusing a single screening offer [33]. Evidence to sup-
port this comes from the fact that nearly 90 % of those
in our Nonuser sample chose not to respond to two
mailings of a short survey even when offered a $10 gift
card to complete it, as compared with a 67 % response
rate for people who had done the test every year for the
past 3 years and a 36 % response rate for people who did
the test in 2012 after 2 years of not doing it. Many of the
96 Nonusers who agreed to be interviewed expressed em-
barrassment about not using the FIT kit, but few indicated
willingness to do it, and several expressed anger at feeling
they were being pressured to use it.
Duncan et al. [33] found that level of satisfaction with
past FOBT screening was a strong behavioral predictor of
adherence, irregular use, or consistent refusal. Our study
results suggest that rather than trying to increase uptake
and annual use of the FIT by changing messaging or out-
reach strategies, it might be more productive to make rela-
tively simple changes to the FIT kit and kit instructions
that would make it easier and less unpleasant to use.
Physical changes to the kit might involve using a tube
with a wider mouth and including a disposable glove
and extra sheet of paper. Changes to the instructions
might include a recommendation to increase water and
fiber intake for a few days to make the bowel movement
sample easier to get into the tube, and reassurance that
the stool sample will not become contaminated if it
comes into contact with toilet water or urine. To address
confusion about when the FIT kit must be used, the in-
structions could mention the shelf life or provide a way
for people to check to see if their kit is no longer usable.
Labeling the return envelope “mail or drop off sample
within X days” could decrease the number of people
who prepare the sample but do not get it processed. Fi-
nally, given that over one-fourth of Converts and nearly
60 % of Nonusers did not realize that the FIT needs to
be done every year, the reason why the FIT needs to be
done annually may need to be communicated more ef-
fectively to those who have not established themselves
as annual users.
Only about one-third of Nonusers who received FIT
kits said that they opened them up, suggesting that
changes made to the mailed kit may not result in greater
uptake among this group unless they are alerted to the
changes and given motivation to open it. Announcing
improvements to the FIT kit on the outer envelope may
be one way to do this.
It is likely that many Nonusers will need a more per-
sonal discussion with a health care provider about why itis important for them personally to get screened and, if
they do not want to use the FIT, whether they would
consider alternative methods, such as sigmoidoscopy or
colonoscopy. A computer-generated letter purportedly
coming from their primary care doctor and automated
calls are obviously not motivating this group. A study by
Wong et al. provides some evidence that allowing people
to choose between the annual FIT and decennial colon-
oscopy after receiving a detailed description of what the
latter entails may result in greater willingness to do the
FIT annually than just being asked to do the FIT, even
if it is an unpleasant experience [34]. Offering patients
the opportunity to make an informed choice about
CRC screening procedure may also address differences
in race-ethnic preferences. Inadomi et al. found that of-
fered the choice, Whites were more likely to prefer colon-
oscopy, while nonwhites were more likely to prefer FOBT
[11]. In an accompanying editorial to the Inadomi et al.
study, Levin discusses the importance of physician-patient
communication and taking a more patient-center ap-
proach for increasing adherence to CRC screening recom-
mendations [35].
Although we frequently saw sex differences in sources
of influence and motivations for getting CRC screening,
we did not see many racial/ethnic differences, suggesting
that targeted messaging may not be needed for boosting
FIT uptake in different segments of the population. Be-
cause Blacks and Latinos were more likely than WhiteNHs
to express concern about exposure to germs/bacteria in
the process of preparing their stool sample, inclusion of a
glove and easier-to-use materials (extra paper if needed,
tube with a wider opening) may improve the acceptability
of the FIT kit to them.
Our study is limited by the low survey response rates
for our Convert and Nonuser groups, despite the $10 in-
centive we offered. In addition to potential nonresponse
bias, the low response rates also reduced our statistical
power to assess racial/ethnic differences in factors that
motivated or deterred use of the FIT kit within and
across these study groups. A second limitation is that we
have no information about nature of the relationships
respondents had with their primary care physicians, nor
the scope of the physician–patient interactions about the
FIT and CRC screening among those who reported some
type of discussion or recommendation. Another limita-
tion, and perhaps most important in terms of interpret-
ing the survey results, is that we have no information
about our study sample’s CRC screening history outside
of what was documented in their health plan records for
calendar years 2010–2012. For example, we do not know
what percentages of Converts and Nonusers in the ori-
ginal and respondent samples had never been screened
for CRC using a blood stool test or other procedure.
This means that both of these groups may be a mix of
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who had been screened for CRC in the past but had not
realized they needed to be screened again, and people
who had a negative experience doing a blood stool test
and decided to avoid doing the FIT. Also, some respon-
dents in the Nonuser group told us that they were up to
date with CRC screening, having had a colonoscopy
done outside of the health plan.
Our study, however, also has several strengths. It fo-
cused on factors influencing uptake of one of the newer,
less costly, and less invasive CRC screening tests. Most
of the previous studies of barriers to CRC screening have
focused on barriers to more invasive procedures (colonos-
copy and sigmoidoscopy), CRC screening by any method,
or multiple-sample FOBT that often involves dietary re-
strictions [4–9, 21–24] rather than on the easier 1-sample
FIT with no dietary restrictions. Another strength is that
we examined differences in social influences, beliefs,
and characteristics of the FIT kit that motivate use and
non-use of the one-sample FIT kit. This was done in
the context of a centralized CRC screening outreach
program within a large health care delivery system that
included offering the FIT for free, mailing the kits to
members’ homes, and formal encouragement to complete
the FIT from the member’s primary care physician via a
separately mailed letter. Most of these prior studies also
drew from populations with different levels of financial
coverage for CRC screening and differential outreach
strategies for CRC screening. Finally, our data on patient-
recommended changes to the standard FIT kit and to
identify gaps in knowledge about how to use the FIT kit
that might lead to making doing the test an easier and a
less unpleasant experience.
Conclusions
This study found that, compared with continuous FIT
users, nonusers and irregular users of the FIT are less in-
trinsically motivated to get CRC screening and more
averse to preparing their stool sample. Feelings of discom-
fort, disgust, and embarrassment with collecting the stool
are the major reasons for lack of uptake indicated by
nonusers. Future controlled trials could show whether
changes to the FIT kit to address these factors might
improve uptake and continuous use.
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